Mergers and Acquisitions

Zimmer Holdings, Inc. tells us that the European Commission (EC) will open a second phase review with respect to Zimmer’s proposed acquisition of Biomet.

Zimmer Holdings, Inc. has acquired ETEX Holdings, Inc. in a deal the details of which have not been disclosed at this time.

MIS Spine company Baxano Surgical, Inc., has issued a new press release that suggests it’s in a holding pattern while touting for a sale.

Spine specialist Baxano having been acquired by TranS1 last year, the emergent Baxano Surgical looks like it might now be on the auctioneer’s block as it talks of reviewing strategic alternatives.

Medtech Titan Medtronic has acquired Dutch Neuro device developer and its novel Deep Brain Stimulation system

The U.S. device sales tax, reimbursement and regulatory challenges and tightened healthcare spending all favour the installed company…so why not buy it?

Win Win as Symmetry Divests OEM Solutions to Tecomet for $450 million

Smith & Nephew is to offer a no-frills service to joint customers in the U.S., but what this amounts to other than not having the rep in attendance, is unclear.

Medtronic, Inc. has completed the acquisition of Visualase, Inc., and its FDA-approved MRI-guided laser and image guided system for minimally invasive neurosurgery.

St. Jude Medical, Inc. is to acquire privately held NeuroTherm, Inc., a manufacturer of interventional pain management therapies, for approximately $200 million in cash.

HeartMate mechanical circulatory support device implantation will benefit from Thoratec’s acquisition of transapical access specialist Apica Cardiovascular.

Stryker Corporation has signed a definitive agreement to acquire assets of Small Bone Innovations, Inc. in an all cash transaction for up to $375 million.

The only news in town this week is that Medtronic and Covidien are to merge, forming a new “offshore” entity. Strategic fit good: Tick. Tax consequences good: Tick.

Announced at the same time as Medtronic’s acquisition of Covidien, Hill Rom has signed a slightly smaller agreement that will see it buy Trumpf Medical for $250 million.

With a combined revenue of $27 Billion, the acquisition of Covidien by Medtronic makes for one helluva company that promises to have fingers in every conceivable medtech pie.

STENTYS is to acquire the assets of Cappella Peel Away Inc to enhance delivery of its next Self-Apposing Stent